AAO 2020: How not to be afraid of performing a posterior capsulorhexis

Video
Conference|AAO

Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.


Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her upcoming AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.

Related Videos
Related Content

ProQR Therapeutics offers update on sale of ophthalmic assets

September 29th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

What to expect from virtual AAO 2020

November 5th 2020

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 25th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 25th 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 29th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

What to expect from virtual AAO 2020

November 5th 2020

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 25th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 25th 2023

ProQR Therapeutics offers update on sale of ophthalmic assets

September 29th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

September 27th 2023

What to expect from virtual AAO 2020

November 5th 2020

World Retina Day: New data from Kiora Pharmaceuticals shines a light on inherited retinal diseases

September 25th 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 25th 2023
© 2023 MJH Life Sciences

All rights reserved.